Please login to the form below

Not currently logged in
Email:
Password:

reimbursement models

This page shows the latest reimbursement models news and features for those working in and with pharma, biotech and healthcare.

Bluebird bio launches beta thalassaemia gene therapy Zynteglo in Germany

Bluebird bio launches beta thalassaemia gene therapy Zynteglo in Germany

With the rapid development of novel gene therapies also comes the need for new payment models that can accommodate the high cost of accessing these treatments. ... A report from The Alliance for Regenerative Medicine (ARM) published in July last year

Latest news

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Assessing the risks in annuity pricing models Assessing the risks in annuity pricing models

    Any of these issues can increase cost or risk. Adapting pricing and reimbursement models to accommodate these therapies could be a significant challenge, especially for higher-cost drugs or those involving ... Manufacturers will need to restructure

  • No incentive for a cure No incentive for a cure

    Each of the different models are variations of a fee-for-service reimbursement model, which have evolved to meet the needs of chronic illnesses. ... Incremental changes may work in the short-term. Incremental changes include solutions such as

  • Lighting the way Lighting the way

    This pathway would better align the current regulatory, reimbursement, evaluation and diffusion processes, and provide companies with tailored support in navigating the new, simplified system. ... reimbursement models” for greater patient access.

  • Market access improvements in Turkey Market access improvements in Turkey

    In 2015 there were 8, 104 products on the reimbursement list, with 292 new ones added. ... company. Alternative reimbursement models. The SGK was first authorised in September 2014 to develop 'alternative reimbursement models' as a new channel through

  • Managing real world data governance Managing real world data governance

    These emerging regulatory and reimbursement models all aim to make treatment provision and access more sensitive to the evolving evidence base, and all require RWD. ... models. Where the appropriate safeguards are in place, authorisation should be based

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics